NAD+ vs. Peptide Therapy: Which Service Should Anchor Your Longevity Clinic Launch?
Published on: 07/08/2026
NAD+ IV therapy versus peptide therapy as the anchor service for a new longevity clinic — operational complexity, patient demand, margins, and the decision framework for sequencing your launch.
Regenerative Health Services & Market Demand



